Abstract
Multidrug-resistant tuberculosis (MDR-TB) is caused by bacteria that are resistant to the most effective anti TB drugs (Isoniazid and Rifampicin) with or without resistance to other drugs. Novel intervention strategies to eliminate this disease based on finding proteins can be used for designing new drugs or new and reliable kits for diagnosis. The aim of this study was to compare the protein profile of MDR-TB with sensitive isolates. Two-dimensional gel electrophoresis (2DE) along with mass spectrometry is a powerful and effective tool to identification and characterization of Mycobacterium tuberculosis. Two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry was used for diagnosis and comparison of proteins. We identified 14 protein spots in MDR-TB isolates that 2DE analysis showed these spots absent in M. tuberculosis sensitive isolates (Rv1876, Rv0379, Rv0147, Rv2031c, Rv3597c, Rv1886c, MT0493, Rv0440, Rv3614c, Rv1626, Rv0443, Rv0475, Rv3057 and unknown protein. The results showed 22 protein spots which were up regulated (or expressed) by the MDR-TB isolates, (Rv1240, Rv3028c, Rv2971, Rv2114c, Rv3311, Rv3699, Rv1023, Rv1308, Rv3774, Rv0831c, Rv2890c, Rv1392, Rv0719, Rv0054, Rv3418c, Rv0462, Rv2215, Rv2986c, Rv3248c and Rv1908c)). Two up regulated protein spots were identified in sensitive isolate (Rv1133c and Rv0685). These data will provide valuable clues in further investigation for suitable TB rapid tests or drug targets against drug resistant and sensitive of M. tuberculosis.
Similar content being viewed by others
References
Andrews, J.R., Gandhi, N.R., Moodley, P., Shah, N.S., Bohlken, L., Moll, A.P., Pillay, M., Friedland, G., and Sturm, A.W., Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa, J. Infect. Dis., 2008, vol. 198, pp. 1582–1589.
Bassili, A., Fitzpatrick, Ch., Qadeer, E., Fatima, R., Floyd, K., and Jaramillo, E., Review article: a systematic review of the effectiveness of hospital and ambulatorybased management of multidrug-resistant tuberculosis, Am. J. Trop. Med. Hyg., 2013, vol. 89, no. 2, pp. 271–280.
Bradford, M.M., A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 1976, vol. 72, pp. 248–254.
Cole, S.T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S.V., Eiglmeier, K., Gas, S., Barry, C.E., Tekaia, F., Badcock, K., Basham, D., Brown, D., Chillingworth, T., Connor, R., Davies, R., and Devlin, K., Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature, 1998, vol. 393, pp. 537–544.
Dunn, M.J., Detection of total proteins on western blot of 2-D polyacrylamide gels, Methods Mol. Biol., 1999, vol. 112, pp. 319–329.
Eichacker, L.A., Granvogl, B., Mirus, O., Muller, B.C., Miess, C., and Schleiff, E., Hiding behind hydrophobicity, J. Biol. Chem., 2004, vol. 279, no. 49, pp. 50915–50922.
Gandhi, N.R., Shah, N.S., Andrews, J.R., Vella, V., Moll, A.P, Scott, M., Weissman, D., Marra, C., Lalloo, U.G., and Friedland, G.H., HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality, Am. J. Respir. Crit. Care Med., 2010, vol. 181, pp. 80–86.
Malen, H., De Souza, G.A., Pathak, Sh., Softeland, T., and Wiker, H.G., Comparison of membrane proteins of Mycobacterium tuberculosis H37Rv and H37Ra strains, BMC Microbiol., 2011, vol. 11, no. 18, pp. 1–10.
Griffin, J.E., Gawronski, J.D., Dejesus, M.A., Ioerger, T.R., Akerley, B.J., and Sassetti, C.M., High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism, PLoS Pathog., 2011, vol. 7, p. 9.
Jiang, X., Zhang, W., Gao, F., and Wang, H., Comparison of the proteome of isoniazid-resistant and susceptible strains of Mycobacterium tuberculosis, Microb. Drug Resist., 2006, vol. 12, no. 4, pp. 231–238.
Krogh, A., Larsson, B.G., and Von Heijae, G., Predicting transmembrane protein topology with Hidden Markov model: application to complete genomes, J. Mol. Biol., 2001, vol. 305, pp. 567–580.
Luetkemeyer, A.F., Getahun, H., Chamie, G., and Lienhardt, C.H., Drug development ensuring people living with HIV are not left behind, Am. J. Respir. Crit. Care Med., 2011, vol. 184, pp. 1107–1113.
Malen, H., Pathak, S., Softeland, T., de Souza, G.A., and Wiker, H.G., Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv, BMC Microbiol., 2010, vol. 10, pp. 132–142.
Mattow, J., Siejak, F., Hagens, K., Becher, D., Albrecht, D., Krah, A., Schmidt, F., Jungblut, P.R., Kaufmann, Sh., and Schaible, U.E., Proteins unique to intraphagosomally grown Mycobacterium tuberculosis, Proteomics, 2006, vol. 6, no. 8, pp. 2485–2494.
Meghji, S., White, P.A., Nair, S.P., Reddi, K., Heron, K., Henderson, B., Zaliani, A., Fossati, G., Mascagni, P., Hunt, J.F., Roberts, M.M., and Coates, A.R., Mycobacterium tuberculosis chaperonin 10 stimulates bone resorption: a potential contributory factor in Pott’s disease, J. Exp Med., 1997, vol. 186, no. 8, pp. 1241–1246.
Moloy, M.P., Gradients two-dimensional electrophoresis of membrane proteins using immobilized PH, Anal. Biochem., 2000, vol. 280, pp. 1–10.
Nathanson, E., Lambregts-van Weezenbeek, C., Rich, M.L., Gupta, R., Bayona, J., Blondal, K., Caminero, J.A., Cegielski, J.P., Danilovits, M., and Espinal, M.A., Multidrug-resistant tuberculosis management in resource-limited settings, Emerg. Infect. Dis., 2006, vol. 12, pp. 1389–1397.
Neelja, S., Prashant, Sh., Kumar, M., Joshi, B., and Bisht, D., Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates, Proteome Sci., 2012, vol. 10, p. 14.
Sharma, P. and Bhavensh, K., Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis, Proteome Sci., 2010, vol. 8, p. 59.
Shevchenko, A., Wilm, M., Vorm, O., and Mann, M., Mass spectrometric sequencing of proteins from silverstained polyacrylamide gels, Anal. Chem., 1996, vol. 68, p. 850–858.
Shevchenko, A., Henrik, T., Jan, H., Jesper, V.O., and Matthias, M., In-gel digestion for mass spectrometric characterization of proteins and proteomes, Nat. Protocol., 2006, vol. 1, no. 6, pp. 2856–2860.
Rengarajan, J., Bloom, B. R., and Rubin, E.J., Genomewide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages, Proc. Natl. Acad. Sci. U.S.A., 2005, vol. 102, pp. 8327–8332.
Rosenkrands, I., King, A., Weldingh, K., Moniatte, M., Moertz, E., and Andersen, P., Towards the proteome of Mycobacterium tuberculosis, Electrophoresis, 2000, vol. 21, no. 17, pp. 3740–3756.
World Health Organization: Global Tuberculosis Report 2014, WHO/HTM/TB/2014.08 WHO. http://wwwwhoint/tb/publications/globalreport/en/
Yanmin, Hu., Geize, R., Besra, G.S., Gurcha, S.S., Liu, A., Rohde, M., Singh, M., and Coates, A., 3-Ketosteroid 9a-hydroxylase is an essential factor in the pathogenesis of Mycobacterium tuberculosis, Mol. Microbiol., 2010, vol. 75, no. 1, pp. 107–121.
Zvi, A., Ariel, N., Fulkerson, J., Sadoff, J. C., and Shafferman, A., Whole genomic identification of bioinformatic analyses, BMC Med. Genomics, 2008, vol. 1, p. 18.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article is published in the original.
Rights and permissions
About this article
Cite this article
Yari, S., Tasbiti, A.H., Ghanei, M. et al. Proteomic analysis of sensitive and multi drug resistant Mycobacterium tuberculosis strains. Microbiology 85, 350–358 (2016). https://doi.org/10.1134/S0026261716030164
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026261716030164